Clinical Study for Perceived Effectiveness Evaluation of Moisturizing Action of Intimate Use Product in Postmenopausal Women
CLIN ST EF EV
1 other identifier
interventional
26
0 countries
N/A
Brief Summary
The purpose of this study is to verify the effectiveness of the investigational product through Subjective Assessment and answered by volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2015
CompletedFirst Posted
Study publicly available on registry
May 6, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedNovember 10, 2015
November 1, 2015
Same day
April 15, 2015
November 9, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the product's efficiency as a moisturizer through subjective evaluation
40 days
Study Arms (1)
Experimental group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Female aged between 45 to 65 years old
- Sexually active volunteers, with a minimum of 1 intercourse per week
- In menopause for at least 6 months;
- Intact skin in the product analysis region;
- No prior reactions to topical products
- Reading, understanding, agreement and signature of the informed consent form
You may not qualify if:
- Use of anti-inflammatory and immunosuppressive ( in the last 30 days and during the study)
- Active skin diseases (local or disseminated) in the evaluation área;
- Diseases that cause imune suppression;
- Endocrine disorders such as thyroid, ovarian or adrenal gland disorders;
- Any infection in the region where the product will be analyzed diagnosed at enrollment;
- Other conditions considered by the investigator physician as reasonable for the disqualification of the individual's participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kley Hertz S/Alead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2015
First Posted
May 6, 2015
Study Start
June 1, 2015
Primary Completion
June 1, 2015
Study Completion
August 1, 2015
Last Updated
November 10, 2015
Record last verified: 2015-11